Cited by 290Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery SystemsPharmacology and Nanomedicine Research

Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment

Open access
Sharifi-Rad, Javad, Quispe, Cristina, Butnariu, Monica, Rotariu, Lia Sanda, Sytar, Oksana, Sestito, Simona, Rapposelli, Simona, Akram, Muhammad +14 more·2021·Cancer Cell International

Abstract

The study describes the current state of knowledge on nanotechnology and its utilization in medicine. The focus in this manuscript was on the properties, usage safety, and potentially valuable applications of chitosan-based nanomaterials. Chitosan nanoparticles have high importance in nanomedicine, biomedical engineering, discovery and development of new drugs. The manuscript reviewed the new studies regarding the use of chitosan-based nanoparticles for creating new release systems with improved bioavailability, increased specificity and sensitivity, and reduced pharmacological toxicity of drugs. Nowadays, effective cancer treatment is a global problem, and recent advances in nanomedicine are of great importance. Special attention was put on the application of chitosan nanoparticles in developing new system for anticancer drug delivery. Pre-clinical and clinical studies support the use of chitosan-based nanoparticles in nanomedicine. This manuscript overviews the last progresses regarding the utilization, stability, and bioavailability of drug nanoencapsulation with chitosan and their safety.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12935-021-02025-4

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 174 · Cited by 290

Research works printed but not linked: 3

  1. [26]Council of Europe The European Pharmacopeia. 6th ed. Vol. 2. Strasburg, France, 2007.
  2. [57]Mukhopadhyay S Vander Heiden MG McCormick F The metabolic landscape of RAS-driven cancers from biology to therapy Nature Cancer 2021 2 271 283 10.1038/s43018-021-00184-x 33870211 PMC8045781 · DOI · Paper page
  3. [125]https://pubmed.ncbi.nlm.nih.gov/28267520/. No Title.

Authors
Sharifi-Rad, J., Quispe, C., Butnariu, M., Rotariu, L. S., Sytar, O., Sestito, S., Rapposelli, S., Akram, M., Iqbal, M., Krishna, A., Kumar, N. V. A., Braga, S. S., Cardoso, S. M., Jafernik, K., Ekiert, H., Cruz-Martins, N., Szopa, A., Villagran, M., Mardones, L., Martorell, M., Docea, A. O., & Calina, D.
Affiliations
  • Arturo Prat University (CL)
  • Univesity of Life Science "King Mihai I" from Timisoara (RO)
  • Taras Shevchenko National University of Kyiv (UA)
  • University of Pisa (IT)
  • Government College University, Faisalabad (PK)
  • Dow University of Health Sciences (PK)
  • Manipal Academy of Higher Education (IN)
  • University of Aveiro (PT)
  • Jagiellonian University (PL)
  • Universidad Católica de la Santísima Concepción (CL)
  • University of Concepción (CL)
  • University of Medicine and Pharmacy of Craiova (RO)
Corresponding author
  • Butnariu, Monica
  • Szopa, Agnieszka
Venue
Cancer Cell International
Published
2021-06-24
Volume
21
Issue
1
Pages
318-318
ISSN
1475-2867 (ISSN-L)
OpenAlex
W3173169652
Cited by
290
References
174
Citations by year
2026: 29 · 2025: 48 · 2024: 72 · 2023: 67 · 2022: 63 · 2021: 11
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell International (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
  • Greater South Information System
Funders
  • Universidade de Aveiro (UIDB/50006/2020)
  • Ministério da Ciência, Tecnologia e Ensino Superior (UIDB 50006/2020)
  • Rede de Química e Tecnologia (UIDB/50006/2020)
  • Laboratório Associado para a Química Verde (UIDB/50006/2020)
  • Fundação para a Ciência e a Tecnologia (UIDB/50006/2020)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
Keywords
chitosan nanoparticles, nanomedicine, anticancer drug delivery, controlled drug release, bioavailability, nanoparticle stability, drug toxicity reduction, cancer therapy, nanomaterial safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review